Pharmaceutical

Generate:Biomedicines secures $273m to advance therapeutic portfolio 

Generate:Biomedicines has secured $273m in Series C financing round to expedite its generative AI therapeutics portfolio.

Sep 15, 2023 - 20:00
Generate:Biomedicines secures $273m to advance therapeutic portfolio 
Generate:Biomedicines has secured $273m in Series C financing round to expedite its generative AI therapeutics portfolio.
Read the original article

Tags:

Previous Article

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

Next Article

No more cookies: How healthcare companies can gain trust for data consent

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Lawmakers circle parents’ rights in gender-affirming care hearing

STAT+: Lawmakers circle parents’ rights in gender-affir...

Jul 30, 2023

CJ-15314 by HK inno.N for Atopic Dermatitis (Atopic Ecz...

Jul 7, 2023

STAT+: J&J loses a patent battle in India over a crucial tuberculosis drug

STAT+: J&J loses a patent battle in India over a crucia...

Mar 24, 2023